Claremont BioSolutions Awarded $3M Phase II SBIR NIH Grant
Claremont BioSolutions announces the award of a $3M Phase II SBIR NIH grant to further develop a sample preparation and detection cartridge for Clostridium difficile.
(PRWeb July 16, 2012)
Read the full story at http://www.prweb.com/releases/2012/7/prweb9696471.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.